We also identified that HDAC1 and HDAC3expression levels were negatively correlated with survival time among gliomapatients, whereas the expression of HDAC4, HDAC5, HDAC6,HDAC11 and SIRT1 was positively correlated with survival time ofpatients with gliomas. Here, HDAC4 is linked to glioma.